TA

Tempus AI

IPO

It's About Time

Public · Chicago, United States · Founded 2015 · $760.0M raised

Headquarters
Chicago, Illinois
Employees
1001–5000
Founded
2015
Business Model
B2B
Total Funding
$760.0M
Last Round
$200.0M Series G+Oct 2021
Rounds
6
Type
Public

About

Tempus AI is a health technology company that applies artificial intelligence to genomic, clinical, and molecular data to enable precision medicine across oncology, neurology, cardiology, and radiology. Its platform includes genomic profiling, AI-powered diagnostics, real-world data products, and clinical trial matching for both healthcare providers and life sciences companies. Founded in 2015 by Eric Lefkofsky, Tempus went public on Nasdaq in 2024.

Summary

Tempus AI is an Artificial Intelligence company based in Chicago, United States, founded in 2015. It has raised $760.0M in total across 6 rounds, most recently a $200.0M Series G+ round in Oct 2021. Investors include Baillie Gifford, Franklin Templeton and Google.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOJun 2024
$410.7M

Sign up to see all 7 rounds

Series C through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tempus AI on Indexed.vc
<a href="https://indexed.vc/companies/tempus-ai"><img src="https://indexed.vc/api/badge/company/tempus-ai" alt="Tempus AI on Indexed.vc" width="260" height="76" /></a>